This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Frederick E. Domann
Introduction
Frederick E. Domann is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of biomedical research, particularly in the area of mitochondrial function and its implications for health.
Latest Patents
Domann holds a patent for "Mitochondrial-targeted cationic nanoparticles comprising CaMKII inhibitors and uses thereof for treating and preventing diseases and disorders associated with CaMKII activity." This patent discloses compositions and methods aimed at treating or preventing diseases linked to mitochondrial CaMKII activity. He has 1 patent to his name.
Career Highlights
Frederick E. Domann is affiliated with the University of Iowa Research Foundation, where he conducts his research and development activities. His work focuses on innovative solutions to complex health issues, leveraging his expertise in mitochondrial biology.
Collaborations
Some of his notable coworkers include Mark E. Anderson and Mei-ling A. Joiner, who contribute to the collaborative research efforts at the University of Iowa.
Conclusion
Frederick E. Domann's work exemplifies the intersection of innovation and health, showcasing how targeted therapies can address critical medical challenges. His contributions continue to influence the field of biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile